American Attorney Thomas Renz reviewed the US Food and Drug Administration (“FDA”) ‘Guidance for Industry’ documents and discovered what he believes is “smoking gun evidence” of pre-meditated murder.
“There’s no other conclusion that I can draw … This is the smoking gun evidence that proves they knew that the gene therapy products they masqueraded as ‘vaccines’ had the ability to shed, cause cancer and kill,” he said.
Thomas “Tom” Renz became well known early on during the covid era for leading federal lawsuits in six US states that challenged shutdowns, mask mandates and the safety of vaccines. He works through the law firm ‘Renz Law’ and regularly publishes articles on his Substack page titled ‘Tom Renz’s Newsletter’.
In an article yesterday, Renz began by explaining that the covid vaccines are not vaccines. “It’s critical that people understand that the covid-19 injections are gene therapy,” he wrote.
He then led his readers through proof that US authorities knew that recipients of covid injections might shed onto others, including those who did not consent to being vaccinated.
Renz then demonstrated how they knew that these injections would cause cancer in 2006, as confirmed by a 2023 study on people with so-called “long covid.”
As if their criminality was not enough, Renz highlighted a science paper that showed their proposed solution to the problem they had created – the cancer caused by covid injections – is another gene therapy product whose recipients also have the potential to shed causing illness in others.
“This shows conspiracy,” Renz concluded.
Covid Injections are Gene Therapy
Moreso, Moderna and Pfizer’s own SEC filings admit that covid injections are gene therapy products, Renz pointed out. Below is an extract from one of Moderna’s quarterly Securities and Exchange Commission (“SEC”) filings that says exactly this:
No mRNA drug has been approved in this new potential class of medicines and may never be approved as a result of efforts by others or us. mRNA drug development has substantial clinical development and regulatory risk due to the novel and unprecedented nature of this new class of medicines.
As a potential new class of medicines, no mRNA medicines have been approved to date by the FDA or other regulatory agency… currently mRNA is considered a gene therapy product by the FDA. [Emphasis added]
Moderna, United States Securities and Exchange Commission, Item 1A. Risk Factors, For the quarterly period ended 30 June 2020, pg. 69 and 70
In March 2015, the US Department of Health and Human Services (“HHS”), the FDA and the Centre for Biologics Evaluation and Research (“CBER”) published a “Guide for Industry.” The Guide defines gene therapies as:
Gene therapies are defined in the FDA guidance document entitled, “Gene Therapy Clinical Trials – Observing Subjects for Delayed Adverse Events” dated November 2006 as “[p]roducts that mediate their effects by transcription and/or translation of transferred genetic material and/or by integrating into the host genome and that are administered as nucleic acids, viruses, or genetically engineered microorganisms. The products may be used to modify cells in vivo or transferred to cells ex vivo prior to administration to the recipient.”
For purposes of this guidance, a vectored vaccine is one that uses a virus or microbe (typically a bacterium), or a DNA plasmid to introduce DNA/RNA encoding for antigens to cells of the body. “Vector” refers to the virus, microbe, or DNA plasmid used as the carrier.
Guide for Industry: Determining the Need for and Content of Environmental Assessments for Gene Therapies, Vectored Vaccines, and Related Recombinant Viral or Microbial Products, FDA, March 2015, Note 5 and 6, pg. 3